Showing 81 - 100 results of 2,426 for search 'harm is (((((resolvedddss. OR removedsdsdss.) OR removed.) OR involved.) OR involves.) OR resolve.)', query time: 0.56s Refine Results
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87

    Trends in the valuation of injury involving the face: an analysis on trial in Rio Grande do Sul, Brazil by Gabriela Cauduro da ROSA (4647883)

    Published 2020
    “…To measure the damage, the assessment of the bodily harm is required. Objective To analyze jurisprudential characteristics involving the valuation of the damage related to facial trauma, highlighting trends Methods It was analyzed secondary data, which are public domain, of the precedents of the Court of Justice of Rio Grande do Sul State from 2008 to 2016. …”
  8. 88
  9. 89
  10. 90

    Table_3_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx by Daniele Mercatelli (6031271)

    Published 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  11. 91

    Table_1_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx by Daniele Mercatelli (6031271)

    Published 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  12. 92

    Table_2_Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling.xlsx by Daniele Mercatelli (6031271)

    Published 2020
    “…<p>Stenodactylin, a highly toxic type 2 ribosome-inactivating protein purified from the caudex of Adenia stenodactyla Harms, is a potential anticancer drug candidate. …”
  13. 93
  14. 94
  15. 95
  16. 96
  17. 97

    Patient Involvement in Preparing Clinical Research Peer-Reviewed Publications or Results Summaries: A Systematic Review by Karen L. Woolley (4910764)

    Published 2018
    “…<div><b>Objective</b></div><div>Although patient involvement in results reporting is being encouraged, relevant evidence must be assessed before developing best practice guidelines. …”
  18. 98
  19. 99
  20. 100